|
|
|
National Stock Number:
6505-01-147-9463
Federal Supply Class:
6505
National Item Identification Number:
011479463
Description:
TEMAZEPAM CAPSULES
|
Manufacturer Information:
| NDC00078-0099-05 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATION | | NDC00078-0099-05 | 0A423 | CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV | | NDC00406-9917-01 | 00CT0 | MALLINCKRODT, INC. | | NDC00378-5050-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC | | NDC00378-5050-01 | 60895 | MYLAN PHARMACEUTICALS INC | | NDC00228-2077-10 | 6LMB8 | ACTAVIS PHARMA, INC. | | RESTORIL | 04520 | NOVARTIS PHARMACEUTICALS CORPORATION | | RESTORIL CAPSULES | 04520 | NOVARTIS PHARMACEUTICALS CORPORATION | | NDC00781-2202-01 | 0THL4 | SANDOZ INC. | | NDC00536-4629-01 | 4V824 | RUGBY GROUP INC | | NDC00406-9917-01 | 6VKK4 | COVIDIEN SALES LLC |
|
Techincal Specification:
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30.000 MILLIGRAMS TEMAZEPAM ACTIVE INGREDIENT | | ADMINISTRATION | ORAL | | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 | | FEATURES PROVIDED | TAMPER PROOF | | PART NAME ASSIGNED BY CONTROLLING AGENCY | TEMAZEPAM CAPSULES 30MG 100S BT. | | PRIMARY CONTAINER TYPE | BOTTLE | | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG | | SPECIAL FEATURES | DISPENSE IN A TIGHT, LIGHT-RESISTANT CONTAINER AS DEFINED IN THE USP USING A CHILD-RESISTANT CLOSURE. STORE AT 20 -25 C ( 68 -77 ). PROTECT FROM LIGHT. |
|